NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
PAR:PAR-25-447.htmlOpportunity type: Resource access, not a cash grant. NHLBI will generate and process omics data for selected studies through its TOPMed 2.0 program. No direct funding to applicants.
Purpose: Accelerate discovery of molecular causes of heart, lung, blood, and sleep (HLBS) disorders by adding high‑quality, standardized multi‑omics data to the public TOPMed resource.
<…
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership in research, training, and education to promote the prevention and treatment of heart, lung, blood and sleep disorders. NHLBI's mission covers many common diseases, such as heart disease and chronic respiratory dise…
Source
Tags
Similar opportunities
-
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
-
Access TOPMed resources to generate multi-omics data for heart, lung, blood, and sleep disorders (X01, no funding)
-
Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)
-
NIH BRAIN Initiative R01 for new theories, models, and methods to analyze complex brain and behavior data (no clinical trials)
-
PRIMED-AI: Validation Center (U54 Clinical Trial Not Allowed) 
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers